In lung cancer cells, miR-33a has already been shown to directly target a potent pro-metastatic/pro-EMT gene, high mobility group AT-hook 2 (HMGA2)33, and this interaction is important to the anti-metastatic cellular phenotypes conferred by miR-33a. Here, HMGA2 is linked to lung carcinoma.